Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session ...

Rocket Lab shares are up on Friday as the company recently completed its first launch of 2026, marking its 80th Electron ...

Rocket Lab stock has continued to skyrocket in 2026 and is currently up 38% year to date. Meanwhile, the S&P 500 is up 1.4%, ...

Rocket Lab looks overvalued despite Neutron/defense catalysts. Click here for more on the RKLB stock prospects.

Rocket Lab completes its first 2026 launch, deploying two satellites for Open Cosmos. Electron rocket proves reliable and ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Rocket Lab USA (NASDAQ:RKLB) shares jumped about 6% on Friday after Morgan Stanley upgraded the stock from Equalweight to ...

As of Friday, January 09, Rocket Lab Corporation’s RKLB share price has surged by 5.63%, which has investors questioning if ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Rocket Lab’s stock price already reflects the impact of major recent milestones and renewed enthusiasm for the space sector, ...